- Global Pharma News & Resources

Online Sales Becomes Major Contributor to Rise of Antimicrobial Susceptibility Tests

Anti-microbial resistance has rapidly one of the largest threats to health care around the world and the field of microbiology is now playing a central role in terms of therapeutic infection management. Unlike earlier, only a limited number of avenues for antimicrobial susceptibility tests are used including the disk diffusion method, and broth microdilution, the latter of which is rapidly becoming a gold standard in the industry.

In recent times, personalized medicines have become popular with a substantial transition for targeted treatments. The trend is a major driver which is promoting the adoption of antimicrobial susceptibility test products. The growth is also supported by increased interest by government bodies, who are investing greater amounts in terms of quality hospital infrastructure, with the growing incidences of infectious diseases.

The demand for antimicrobial susceptibility test kits is not limited to diagnostic laboratories and hospitals, but is also being used in biotech and pharmaceutical sectors with the objective of drug development, which will also contribute to the growth of the industry.

Request Sample Report-

Manufacturers Aim to Build Presence through Online Sales

Online sales is slated to become key to the distribution of antimicrobial susceptibility test kits, which is set to evolve to become mainstream during the forecast period till 2025. A large number of vendors are bolstering the value of brand recognition through effective efforts and strategies for marketing and promotions.

The development of these new online channels is expected to translate into minimal costs, owing to the elimination of the need to maintain brick and mortar shop infrastructure. These changes are expected to have a positive impact on the antimicrobial susceptibility tests.

Further, North America is set to continue being the top market for antimicrobial susceptibility tests, which is expected to increase by 2025. Major trends including higher cases of resistance to drugs by microbes, barriers from stringent regulations, the effect of traditional methods in the region.

In addition, North America also has easier access to cutting edge technologies, which is helping in the development of new products. On the other hand, the strict rules associated with health care is expected to lengthen the time needed for approval, which also influences public-private collaborations.

Read Report Overview-

Research Costs Restrict Emerging and Small Scale Players

Manufacturers in the antimicrobial susceptibility tests market have been struggling to gain higher returns on their investments into the industry. Unlike therapeutics, which involve a long term treatment, ant-biotics are used by patients for short periods. The limited consumption of such drugs is also reducing the returns in terms of the amount of money spent on research and development activities.

The requirements of high capital rates is expected to push major manufacturers ahead of small and regional players, owing to cost restrictions. As a result small and medium enterprises are likely to struggle to get major gains in the industry. These players are also expected to face challenges in terms of technology and regulations, which will hamper the marketability of their offerings for the long term.

Request Research Methodology-

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us


11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States



Editor Details

Last Updated: 16-Dec-2019